Synchron Raises $75M Series C Led By Arch Venture Partners To Advance Endovascular Brain-Computer Interface
Synchron Raises $75M Series C Led By Arch Venture Partners To Advance Endovascular Brain-Computer Interface
12/15/22, 1:02 PM
Location
new yorkMoney raised
$75 million
Industry
medical equipment manufacturing
Round Type
series c
Investors
Id8 Investments, Forepont Capital Partners, Neuro Technology Investors, Khosla Ventures, Moore Strategic Ventures, Alumni Ventures, Arch Venture Partners
Synchron, the endovascular brain-computer interface (BCI) company, announced today an oversubscribed $75 million Series C financing round led by ARCH Venture Partners. Gates Frontier, Bezos Expeditions, Reliance Digital Health Limited, Greenoaks, Alumni Ventures, Moore Strategic Ventures, and Project X join ARCH as new additional investors. Existing investors, including Khosla Ventures, NeuroTechnology Investors, METIS, Forepont Capital Partners, ID8 Investments, Shanda Group and University of Melbourne participated in the round. The Series C funding brings the total amount raised since inception to $145 million.